cinnarizine
Modify Date: 2024-01-02 22:24:24
cinnarizine structure
|
Common Name | cinnarizine | ||
|---|---|---|---|---|
| CAS Number | 298-57-7 | Molecular Weight | 368.514 | |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 509.2±38.0 °C at 760 mmHg | |
| Molecular Formula | C26H28N2 | Melting Point | 117-120ºC | |
| MSDS | Chinese USA | Flash Point | 229.8±14.6 °C | |
Use of cinnarizineCinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. |
| Name | cinnarizine |
|---|---|
| Synonym | More Synonyms |
| Description | Cinnarizine is an antihistamine and a calcium channel blocker, promote cerebral blood flow, used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. |
|---|---|
| Related Catalog |
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 509.2±38.0 °C at 760 mmHg |
| Melting Point | 117-120ºC |
| Molecular Formula | C26H28N2 |
| Molecular Weight | 368.514 |
| Flash Point | 229.8±14.6 °C |
| Exact Mass | 368.225250 |
| PSA | 6.48000 |
| LogP | 4.63 |
| Vapour Pressure | 0.0±1.3 mmHg at 25°C |
| Index of Refraction | 1.626 |
| Storage condition | Refrigerator |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Hazard Codes | Xn |
| Risk Phrases | R20/22 |
| Safety Phrases | S22-S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 2 |
| RTECS | TL3430000 |
| HS Code | 2933599090 |
|
~79%
cinnarizine CAS#:298-57-7 |
| Literature: RSC Advances, , vol. 3, # 43 p. 20708 - 20718 |
|
~75%
cinnarizine CAS#:298-57-7 |
| Literature: Journal of the American Chemical Society, , vol. 134, # 51 p. 20613 - 20616 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Iron oxide induced enhancement of mucoadhesive potential of Eudragit RLPO: formulation, evaluation and optimization of mucoadhesive drug delivery system.
Expert Opin. Drug Deliv. 10(9) , 1179-91, (2013) The objective of the study was to investigate the effect of iron oxide in the development of mucoadhesive tablets of cinnarizine using Eudragit RLPO polymer. A simplex lattice design was employed for ... |
|
|
A combination turbidity and supernatant microplate assay to rank-order the supersaturation limits of early drug candidates.
J. Pharm. Sci. 103(10) , 3022-32, (2014) A unique opportunity exists at the drug discovery stage to overcome inherently poor solubility by selecting drug candidates with superior supersaturation propensity. Existing supersaturation assays co... |
|
|
Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
J. Phys. Chem. B 118(33) , 9974-82, (2014) Amorphous forms of drugs are increasingly being used to deliver poorly water-soluble compounds. Therefore, understanding the magnitude and origin of differences in crystallization kinetics is highly i... |
| 1-Diphenylmethyl-4-trans-cinnamylpiperazine |
| stugeron |
| 1-trans-Cinnamyl-4-diphenylmethylpiperazine |
| Denapol |
| 1-(diphenylmethyl)-4-(3-phenyl-2-propenyl)-piperazine |
| Siptazin |
| Artate |
| Carecin |
| Piperazine, 1-(diphenylmethyl)-4-[(2E)-3-phenyl-2-propen-1-yl]- |
| Processine |
| piperazine, 1-(diphenylmethyl)-4-[(2E)-3-phenyl-2-propenyl]- |
| Apotomin |
| Mitronal |
| Piperazine, 1-cinnamyl-4- (diphenylmethyl)-, (E)- |
| Glanil |
| Stutgin |
| Aplactan |
| Labyrin |
| N-Benzhydryl-N'-trans-cinnamylpiperazine |
| 1-(diphenylmethyl)-4-[(2E)-3-phenylprop-2-en-1-yl]piperazine |
| Cinnacet |
| Toliman |
| Cinazyn |
| Midronal |
| Sedatromin |
| Olamin |
| Cinnageron |
| Katoseran |
| Giganten |
| Ixertol |
| cinnarizine |
| Cinnipirine |
| Hilactan |
| EINECS 206-064-8 |
| Corathiem |
| Spaderizine |
| 1-Cinnamyl-4-benzhydrylpiperazine |
| Stutgeron |
| Aplexal |
| Cerebolan |
| Eglen |
| 1-(Diphenylmethyl)-4-[(2E)-3-phenyl-2-propen-1-yl]piperazine |
| MFCD00056037 |
| Folcodal |
| Cinaperazine |
| Piperazine, 1- (diphenylmethyl)-4-(3-phenyl-2-propenyl)-, (E)- |
| UNII-3DI2E1X18L |